In this article 11V-FF WMG PNT Follow your favorite stocksCREATE FREE ACCOUNT Co-CEOs, Neil Blumenthal & Dave Gilboa of Warby Parker at the NYSE, September 29, 2021. Source: NYSE Check out the companies making headlines before the bell. Warby Parker — Warby Parker jumped about 4% after Evercore ISI upgraded the eyeglass retailer to an
admin
While the adult botanical industry presents high risks, regulatory momentum may bolster the case of cannabis stocks to make you rich. Specifically, a recent report from the Department of Health and Human Services (HHS) recommended that the U.S. Drug Enforcement Administration (DEA) reschedule marijuana from its present Schedule I status to Schedule III. Moreover, the
Always an uncomfortable topic, the controversial tagline of stocks to sell generates a range of human emotions. At the same time, this is a necessary conversation. Fundamentally, success in the market is about knowing when to buy and when to sell. Just watch a baseball game. On rare occasions in the modern game, a starting
Taylor Swift is a phenomenon that has captured the attention of millions around the world. But importantly, Swift has captured the wallets of these people as well. In fact, she’s been so successful that many have started referring to her business acumen as “Swiftonomics.” The Eras Tour grossed some $2.2 billion — just in America.
McCormick spices are displayed on a shelf at a supermarket on March 28, 2023 in San Anselmo, California. Spice Maker McCormick reported better-than-expected first quarter earnings with revenues of $1.57 billion compared to $1.52 billion one year ago. Justin Sullivan | Getty Images News | Getty Images Check out the companies making headlines in midday
In the landscape of modern medicine, a trio of biotech giants may rewrite the rules of healthcare. In a world where precision and personalization have become the holy grail of treatment, these three companies are emerging as pioneers, guiding the world into a new era of therapeutic possibilities. Imagine a cancer treatment so versatile and
Solar stocks have been under pressure in 2023 as the global energy landscape has shifted. The resurgence of fossil fuels, especially natural gas, has made renewable energy sources less competitive and attractive. The rising cost of capital has also weighed on the solar industry, which relies heavily on debt financing and subsidies. In this challenging
The Russell 2000 Index has long been known as the best way to track the small to mid-cap investing universe. The index measures the performance of about 2,000 of the smallest publicly traded companies in the United States. It boasts a 15-year return of 8.36%. Numerous investors often look to it in order to capitalize
Check out the companies making headlines before the bell: Rivian Automotive — Shares popped 3.3% in the premarket. Evercore ISI upgraded Rivian Automotive to outperform from in line, and raised its price target, saying the electric truck maker could be the next Tesla and BYD. The Sphere is seen during the opening night with U2:UV
After a tumultuous summer, history says we might be due for a rally into year-end. According to Ryan Detrick at the Carson Group, when stocks fall more than 1% in August and September, they usually see a bounce in October. Overall, software-as-a-service (SaaS) stocks have done well this year. And the outlook is still favorable
The lithium battery market is booming in 2023, thanks to the surge in electric vehicle sales. Consumers are switching to greener and cheaper alternatives to gas-powered cars, and governments are offering incentives and subsidies to encourage the transition. However, on the supply side of the market, a glut of lithium, precipitating from the rise of
Autologous chimeric antigen receptor T cell therapy is 0ne of the most promising, relatively new types of cancer treatments. CAR T involves “reprogramming” patients’ T cells, which fight hostile cells within the body. Specifically, CAR T treatments work by reconfiguring T cells so that they attack proteins found on tumors. CAR T also attacks other
The Sphere is seen during its opening night with the U2:UV Achtung Baby Live concert at the Venetian Resort in Las Vegas on Sept. 29, 2023. Tayfun Coskun | Anadolu Agency | Getty Images Check out the companies making headlines in midday trading. Sphere Entertainment — Shares of the media and entertainment company climbed 10%
In recent times, the buzzing topic in the realm of auto stocks has been the strike initiated by the United Auto Workers Union. However, peering beyond this immediate hurdle, long-term investors should be more interested in the prospects of autonomous driving and the proliferation of electric vehicles (EVs). These transformative trends, vibrant in potential, should
The recent crypto rally has sparked excitement, particularly in speculative assets, amid rumors of a new uptrend. And yet, caution is advised. This rally may not sustain for long due to economic concerns and the underperformance of alternative cryptocurrencies. Consequently, high-risk projects are doubtful to perform strongly in the short term, especially until monetary policy
After a strong summer, Archer Aviation (NYSE:ACHR) stock lost altitude in September. Does this mean it’s time for investors to give up on Archer Aviation? Not necessarily, but you’ll definitely want to keep your share position size small and be realistic with your time frame. Archer Aviation will not commercialize its electric vertical take-off and landing
In this article FDX PINS CRM ADBE MSFT Follow your favorite stocksCREATE FREE ACCOUNT Shantanu Narayen, CEO, Adobe. Mark Neuling | CNBC Investors are grappling with uncertainty after a difficult September left the major averages reeling. However, the current scenario also offers an opportunity to pick stocks that could generate attractive returns despite short-term pressures.
Goldman Sachs economists estimate that a government shutdown would decrease growth by roughly 0.2% per week due to federal workers going unpaid. However, these economists anticipate growth to rebound by the same amount in the quarter following the shutdown as federal work resumes paired with employees receiving back pay. This has led to the rise
The past few years have seen several breakthroughs in the field of weight-loss drugs, as the FDA moved to approve two new medications that promise to help people shed pounds without major side effects. These drugs, called Liraglutide and Semaglutide, work by mimicking a hormone that regulates appetite and blood sugar levels, and they can
It continues to be an uneven playing field for tech stocks. While some companies are continuing to knock the cover off the ball, others are struggling and in decline. Of course the current market selloff isn’t helping. But the underlying fundamentals of many tech stocks remain extremely strong and position them for big gains once
- « Previous Page
- 1
- …
- 83
- 84
- 85
- 86
- 87
- …
- 483
- Next Page »